SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anlon Healthcare informs about investors meet

22 Sep 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulation) read with part A of Schedule III of the Regulations, Anlon Healthcare has informed that the management of the Company will be interacting with Analyst/Investor ‘Seeberg’ on Thursday, September 25, 2025 at 04:00 pm IST. The meeting may be cancelled, rescheduled or postponed due to the exigencies on the part of both the parties. The company has informed that discussion during the meeting will be based on publicly available information/ documents and no unpublished price-sensitive information (‘UPSI’) is proposed to be discussed during the interactions.

The above information is a part of company’s filings submitted to BSE.


Anlon Healthcare Share Price

15.85 1.47 (10.22%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×